Fairway interviewed by the Harvard Crimson: Biotech Innovation Pressures

Fairway interviewed by the Harvard Crimson: Biotech Innovation...

Facing Wary Investors and the Lure of Outsourcing, Cambridge Biotech Firms Turn Away From Basic Research Tariff pressures, a changing regulatory environment, and risk-averse investor...